Recent cancer drug development with xanthone structures.
about
Sparstolonin B, a novel plant derived compound, arrests cell cycle and induces apoptosis in N-myc amplified and N-myc nonamplified neuroblastoma cellsA polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrierSynthesis, characterization and anticancer activity of tanshinone I grafted low molecular chitosan.Intermolecular C-O addition of carboxylic acids to arynes.Xanthone dimers: a compound family which is both common and privileged.Cytotoxic and NF-κB inhibitory constituents of the stems of Cratoxylum cochinchinense and their semisynthetic analoguesAntioxidant properties of xanthones from Calophyllum brasiliense: prevention of oxidative damage induced by FeSO₄.Molecular Cloning and Characterization of a Xanthone Prenyltransferase from Hypericum calycinum Cell Cultures.Targeting truncated retinoid X receptor-α by CF31 induces TNF-α-dependent apoptosis.Intermolecular C-O Addition of Carboxylic Acids to Arynes: Synthesis of o-Hydroxyaryl Ketones, Xanthones, 4-Chromanones, and Flavones14-Bromo-12-chloro-2,16-dioxa-penta-cyclo-[7.7.5.0(1,21).0(3,8).0(10,15)]henicosa-3(8),10,12,14-tetra-ene-7,20-dione.Synthesis and biological evaluation of 1, 3-dihydroxyxanthone mannich base derivatives as anticholinesterase agents.Early state research on antifungal natural products.Isolation and structural modifications of ananixanthone from Calophyllum teysmannii and their cytotoxic activities.New dimeric members of the phomoxanthone family: phomolactonexanthones A, B and deacetylphomoxanthone C isolated from the fungus Phomopsis sp.Antiproliferative activities of Garcinia bracteata extract and its active ingredient, isobractatin, against human tumor cell lines.Anti-tumour effects of xanthone derivatives and the possible mechanisms of action.Synthesis of fluorinated benzophenones, xanthones, acridones, and thioxanthones by iterative nucleophilic aromatic substitution.Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review.Modulation of the Nur77-Bcl-2 apoptotic pathway by p38α MAPK.Contribution of reactive oxygen species to the anticancer activity of aminoalkanol derivatives of xanthone.Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.Antibacterial and EGFR-tyrosine kinase inhibitory activities of polyhydroxylated xanthones from Garcinia succifolia.
P2860
Q28538332-DB566A70-BF05-4999-929C-C54F8A9CFC04Q28544909-D4A8ECE9-52FB-4255-85EE-6157B2454DFDQ31130744-E970B1F5-7F38-43A6-B859-B90623DB881CQ33989460-A377E3C9-F55B-412D-AA0D-BCA96B57E5C6Q34438968-30B2AD0D-903D-48D1-9E1A-9989F688BF8FQ35012047-9A098F86-E1F2-4CA1-B44F-8A31832C5D29Q35016012-B18F99A0-E021-4792-B9A8-6EF324179825Q35765546-7D0FAC06-C18E-400E-9627-57A2F841FCD8Q36510879-E4308547-35C1-471A-891C-D12192F1EC14Q36693591-6CE8ECCB-F7CF-499D-8A7E-EF053C961B8BQ36827741-AFE74033-5B1B-4A05-9F54-2D2692C37D5BQ36905746-B273C046-8891-4E07-B193-09A4727582BEQ38194442-E8B2C4B4-F8D2-4010-87C0-CAE48313FF71Q38694494-22A23BB6-21C3-4A64-830D-AF691C0185C5Q39043739-6B41B8BB-F60A-4D26-9740-263ED6903C93Q39132902-9DE97FB0-E1E8-431A-AE47-A4E40B89DE7CQ39688446-A12793C6-8ABB-4AED-BFEE-49A4C9EDA9C3Q40350289-9ACC07D8-7FA1-437C-999E-C019C34A0F04Q41258130-87527976-8996-4648-AA45-AA5AD80FBAAEQ42378374-49B263A8-5138-4AAA-8D6C-0E1259D96184Q46265828-0D9214D1-33E1-43DA-BCE2-861DBADA919AQ47789316-97CD8895-B2B7-443A-A8DC-01698F4A3F51Q55069634-05452F0F-5A7C-4D01-8CD4-130953F816A7
P2860
Recent cancer drug development with xanthone structures.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent cancer drug development with xanthone structures.
@en
Recent cancer drug development with xanthone structures.
@nl
type
label
Recent cancer drug development with xanthone structures.
@en
Recent cancer drug development with xanthone structures.
@nl
prefLabel
Recent cancer drug development with xanthone structures.
@en
Recent cancer drug development with xanthone structures.
@nl
P2860
P356
P1476
Recent cancer drug development with xanthone structures.
@en
P2093
Younghwa Na
P2860
P304
P356
10.1211/JPP.61.06.0002
P577
2009-06-01T00:00:00Z